Position in IONS
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$35,169,377
-$6,382,280 QoQ
Shares Held
468,363
-10.8% QoQ
Ownership
0.283%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
23 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in IONS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026FIRST TRUST ADVISORS LP holds $2,375,392,616 across 80 Biotechnology names. IONS ranks #22 (1.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
346,855 | $267,994,047 | |
| 2 | INCY |
Incyte Corp
|
1,500,792 | $141,254,543 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
306,461 | $136,847,094 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
382,701 | $126,624,279 | |
| 5 | MRNA |
Moderna, Inc.
|
2,392,693 | $121,548,804 | |
| 6 | EXEL |
Exelixis, Inc.
|
2,534,992 | $108,725,806 | |
| 7 | AXSM |
Axsome Therapeutics, Inc.
|
577,479 | $97,605,500 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
1,482,340 | $95,803,634 |
All Filings in IONS
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $35,169,377 | 468,363 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $41,551,657 | 525,239 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $4,921,154 | 75,224 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $2,233,065 | 56,519 | Shares | Sole | 2025-08-13 | |
| 2024-09-30 | $16,116,138 | 402,300 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $771,806 | 16,194 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $7,623,444 | 175,858 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $55,534,160 | 1,097,730 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $51,482,647 | 1,134,979 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $54,284,002 | 1,323,032 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $58,575,822 | 1,638,943 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $67,265,839 | 1,780,933 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $91,877,209 | 2,077,260 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $59,085,956 | 1,596,055 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $59,867,381 | 1,616,290 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $51,122,765 | 1,680,012 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $56,365,613 | 1,680,549 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $60,730,490 | 1,522,449 | Shares | Sole | 2021-10-12 | |
| 2021-03-31 | $52,504,692 | 1,167,809 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $78,417,078 | 1,386,931 | Shares | Sole | 2021-02-02 | |
| 2020-09-30 | $66,321,481 | 1,397,713 | Shares | Sole | 2020-11-05 | |
| 2020-06-30 | $77,544,604 | 1,315,207 | Shares | Sole | 2020-07-22 | |
| 2020-03-31 | $45,032,923 | 952,473 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||